These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1493 related items for PubMed ID: 9815582

  • 1. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M, Drullinsky P, Guillem J, Moore MA.
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [Abstract] [Full Text] [Related]

  • 2. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M, Albanell J, Drullinsky P, Han W, Guillem J, Scher HI, Reuter V, Moore MA.
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
    Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, Yokoyama T.
    Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
    [Abstract] [Full Text] [Related]

  • 5. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H, Siewert JR.
    J Clin Oncol; 2004 May 15; 22(10):1807-14. PubMed ID: 15143073
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C, de Juan C, Diaz-Lopez A, Sanchez-Pernaute A, Torres AJ, Diaz-Rubio E, Balibrea JL, Benito M, Iniesta P.
    Cancer; 2006 Feb 01; 106(3):541-51. PubMed ID: 16388518
    [Abstract] [Full Text] [Related]

  • 9. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
    Kanamaru T, Tanaka K, Kotani J, Ueno K, Yamamoto M, Idei Y, Hisatomi H, Takeyama Y.
    Int J Mol Med; 2002 Aug 01; 10(2):205-10. PubMed ID: 12119560
    [Abstract] [Full Text] [Related]

  • 10. Telomerase activity in different clinical staging of colorectal adenocarcinoma.
    Lukman K, Maskoen AM, Achmad TH, Hanafi B, Karnadihardja W.
    Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():491-7. PubMed ID: 10895200
    [Abstract] [Full Text] [Related]

  • 11. Telomerase activity in ovarian tumors.
    Murakami J, Nagai N, Ohama K, Tahara H, Ide T.
    Cancer; 1997 Sep 15; 80(6):1085-92. PubMed ID: 9305709
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of telomerase in the development and progression of colon cancer.
    Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, Berti P, Spisni R, Galleri D, Materazzi G, Basolo F, Miccoli P, Pingitore R, Fontanini G.
    Int J Mol Med; 2002 Nov 15; 10(5):589-92. PubMed ID: 12373297
    [Abstract] [Full Text] [Related]

  • 13. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
    Fujita M, Tomita S, Fukui H, Ueda Y, Fujimori T.
    J Exp Clin Cancer Res; 1999 Mar 15; 18(1):119-24. PubMed ID: 10374691
    [Abstract] [Full Text] [Related]

  • 14. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
    Bonatz G, Frahm SO, Klapper W, Helfenstein A, Heidorn K, Jonat W, Krupp G, Parwaresch R, Rudolph P.
    Hum Pathol; 2001 Jun 15; 32(6):605-14. PubMed ID: 11431715
    [Abstract] [Full Text] [Related]

  • 15. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
    Takagi S, Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takahashi S, Negoro K, Shimosegawa T, Toyota T.
    Cancer; 1999 Oct 15; 86(8):1431-6. PubMed ID: 10526269
    [Abstract] [Full Text] [Related]

  • 16. Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report.
    Kammori M, Nakamura K, Kanauchi H, Obara T, Kawahara M, Mimura Y, Kaminishi M, Takubo K.
    World J Surg; 2002 Sep 15; 26(9):1083-7. PubMed ID: 12209236
    [Abstract] [Full Text] [Related]

  • 17. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD, Lynch FJ, Groshen S, Xiong YP, Sherrod A, Caradonna SJ, Stoehlmacher J, Lenz HJ.
    Cancer Res; 2000 Jul 01; 60(13):3493-503. PubMed ID: 10910061
    [Abstract] [Full Text] [Related]

  • 18. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N.
    Cancer Res; 1998 May 15; 58(10):2117-25. PubMed ID: 9605755
    [Abstract] [Full Text] [Related]

  • 19. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
    Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, Ide T, Tahara E.
    Clin Cancer Res; 1995 Nov 15; 1(11):1245-51. PubMed ID: 9815918
    [Abstract] [Full Text] [Related]

  • 20. Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
    Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S.
    Cancer Res; 1995 Jun 15; 55(12):2533-6. PubMed ID: 7780964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.